(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

Study results support advancing SGX945 in this difficult-to-treat orphan disease Results suggest potential durability of response for maintenance therapy PRINCETON, N.J., Dec. 18, 2025 ...

Tiny charming immune cells called microglia protect the central nervous system (CNS) in a multitude of ways: They provide innate immunity, shape ...

As temperatures swing unpredictably between warm and cool, many people feel more tired and vulnerable to seasonal illnesses.

Tiny charming immune cells called microglia protect the central nervous system in a multitude of ways: They provide innate immunity, shape neurodevelopment, maintain homeostasis and modulate ...

Tiny immune cells called microglia protect the central nervous system (CNS) in a multitude of ways: They provide innate immunity, shape neurodevelopment, maintain homeostasis and modulate neurological ...

In a study published in Nature Ecology and Evolution, scientists show that the SAMD9 and SAMD9L genes, key players in ...

Two studies suggest that T cells with stem-cell-like properties could work with antibody therapies to control HIV after a person stops taking antiviral pills.

Despite being among the great scientific breakthroughs of all time, vaccines are under fire as top US government officials ...

Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...

Sanofi ( SAN:CA) Evercore 8th Annual Healthcare Conference December 2, 2025 11:30 AM EST Thank you guys for being here. Pleasure to have the CEO of Sanofi, but even more importantly, Chairman-elect of ...

AN ENLIGHTENING session, entitled ‘Emerging therapeutic frontiers in cardiology: what does the future hold?’, delivered at ...